Skip to main content
Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.650
+0.170 (6.85%)
At close: Mar 9, 2026, 4:00 PM EDT
2.670
+0.020 (0.75%)
After-hours: Mar 9, 2026, 5:51 PM EDT

CNTB Revenue

Connect Biopharma Holdings had revenue of $16.00K in the quarter ending September 30, 2025, a decrease of -98.69%. This brings the company's revenue in the last twelve months to $762.00K, down -96.99% year-over-year. In the year 2024, Connect Biopharma Holdings had annual revenue of $26.03M.

Revenue (ttm)
$762.00K
Revenue Growth
-96.99%
P/S Ratio
192.95
Revenue / Employee
$12,290
Employees
62
Market Cap
148.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202426.03M--
Dec 31, 2023---
Dec 31, 2022---
Jan 1, 2022---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 127.63M
Spero Therapeutics 40.55M
Sangamo Therapeutics 32.88M
Zentalis Pharmaceuticals 26.87M
Oramed Pharmaceuticals 2.00M
Cardiff Oncology 593.00K
Artiva Biotherapeutics 251.00K
Adagene 103.20K
Revenue Rankings

CNTB News

More News